The intracellular free Ca 2+ concentration ([Ca 2+ ] i ) is a key regulator of fundamental cellular processes. Ca 2+ acts as a second messenger via specialized Ca 2+ -binding proteins (CaBPs) that show Ca 2+ -dependent regulation of downstream effectors. Distinct from such Ca 2+ sensors are pure buffers, which bind Ca 2+ but lack a Ca 2+ -dependent interaction with other proteins (Celio et al. 1996) . In the following we will use 'CaBP' as the generic term for both sensors and buffers.
Owing to its potent action, the spatiotemporal extent of [Ca 2+ ] i is strictly controlled by endogenous CaBPs and clearance mechanisms. In this process, mobile CaBPs compete with immobile binding sites and pumps for Ca 2+ binding. They increase the range of Ca 2+ signals even if they diffuse at a slower rate than free Ca 2+ ions (for review see Augustine et al. 2003) . Besides their binding kinetics, the mobility of the individual CaBPs and their action as buffer or sensor are therefore major determinants of cellular Ca 2+ signalling.
The CaBP parvalbumin (PV) is expressed in large concentrations in distinct subpopulations of neurones, including specific interneurones in many brain regions and cerebellar Purkinje neurones (PNs) (Celio 1990; Baimbridge et al. 1992) . It belongs to the family of EF-hand CaBPs and was the first member of this family to be discovered (reviewed in Celio et al. 1996) . The most prominent member of the EF-hand family is calmodulin, which appears to be the primary Ca 2+ sensor in eukaryotic cells. On the contrary, PV is typically considered to function as a pure Ca 2+ buffer, although to our knowledge the absence of downstream PV targets has only been shown in frog skeletal muscle cells (Maughan and Godt 1999) and in spines and dendrites of rodent PNs (Schmidt et al. 2003a) . Although it is tempting to generalize the functional classification of PV as a pure buffer based on these observations, we recently found that the related CaBP calbindin-D28k binds to myo-inositol-monophosphatase in spiny dendrites of PNs but not in axons (Schmidt et al. 2005) . Thus, although PV lacks an interaction partner in dendrites (Schmidt et al. 2003a) , this observation cannot readily be transferred to other structures, not even within the same cell. Under physiological conditions, the Ca 2+ -binding kinetic of PV is slow because it has to be preceded by unbinding of Mg 2+ for which PV also shows significant affinity. Furthermore, its Ca 2+ dissociation rate is rather slow (Lee et al. 2000) . As a result of this particular binding characteristic, PV accelerates the initial decay rate of Ca 2+ transients and introduces a second component to the decay that summates during repetitive stimulation (Lee et al. 2000; Schmidt et al. 2003b; Collin et al. 2005) . Although the functional relevance of this peculiar PV action is still obscure in dendritic Ca 2+ signalling, for presynaptic sites it has been shown that it modulates short-term plasticity and delayed transmitter release (Caillard et al. 2000; Collin et al. 2005) . Furthermore, PV expression in PNs appears to be 10-fold stronger in the axon ( ‡ 1 mM) than in the perikarion and dendrites (50-100 lM) (Kosaka et al. 1993) , which might hint towards a predominantly axonal function. In the light of these findings, it was of particular interest to determine the axonal diffusion of PV and to clarify whether or not a binding partner for PV is present in the axon.
One means of quantifying the cytosolic mobility of CaBPs and to concomitantly identify target proteins, i.e. a possible sensor function, is by fluorescence recovery after photobleaching (FRAP; for a review see Reits and Neefjes 2001; Sprague et al. 2004) . In the present study, we used two-photon FRAP to investigate the mobility of dyelabelled PV (PV*) in the axon and to search for possible axonal binding partners. In addition, we analysed the mobility of PV* in the soma and nucleus of PNs. Our results indicate that PV* freely diffuses in all three compartments and that none of them contains a large ( ‡ 9 kDa) or immobile interaction partner, indicating that PV is indeed a mere Ca 2+ buffer and has no additional sensor function in rodent PNs.
Experimental procedures
Slice preparation and solutions Acute cerebellar brain slices were prepared from 21-24-day-old mice that were decapitated under isoflurane (Curamed, Karlsruhe, Germany) anaesthesia. The vermis was removed and mounted in a chamber filled with cooled (0-2°C) artificial cerebrospinal fluid (ACSF) below). Parasagittal slices 200 lm thick were cut using a vibratome (HR2, Sigmann Elektronik, Hüffenhardt, Germany) and kept in ACSF at 35°C for 45 min before they were transferred to the recording chamber. Experiments were performed at 20-22°C.
The ACSF contained 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 1 mM MgCl 2 , 2 mM CaCl 2 and 20 mM glucose (pH 7.3-7.4 at 20-22°C when gassed with 95% O 2 and 5% CO 2 ). The pipette solution was composed of 140 mM potassium gluconate, 10 mM NaCl, 3 mM Mg-ATP, 0.3 mM Na-GTP, 10 mM HEPES, 0.1 mM dye-labelled PV or 0.5 mM fluorescein dextran (FD; 10 or 40 kDa) dissolved in purified water (Sigma, St Louis, MO, USA). The pH was adjusted to 7.3 with KOH. All chemicals were from Sigma. Purified rat recombinant PV expressed in Escherichia coli was labelled with Alexa-488 (Molecular Probes, Eugene, OR, USA) as described previously (Schmidt et al. 2003a) . Labelling conditions (pH 9.0) were selected to preferentially label the a-amino group of PV, while e-amino groups were not labelled significantly. The labelled protein was purified on a size exclusion column (20 · 0.8 cm, gel volume 10 mL) containing Bio-Gel P-6 (medium, fractionation range 1-6 kDa; Bio-Rad, Hercules, CA, USA) to remove the unbound dye. In general, 0.3-1 mL labelling reaction mixture was applied to the column and eluted with buffer [50 mM (NH 4 )HCO 3 , 0.1 mM CaCl 2 , pH 8.3]. The molecular Alexa/PV ratio was $ 0.8.
Dye loading and electrical recordings
PNs were equilibrated with the dye-containing pipette solution for 30 min in the whole-cell patch-clamp configuration. Up to ) 300 pA holding current was injected to keep the membrane potential at ) 60 to ) 65 mV using an Axopatch 200A amplifier (Axon Instruments Inc., Union City, CA, USA), a LIH 1600 AD/DA converter and Patch Master 1.0 software (HEKA, Lamprecht, Germany). The latter components were also used to control a Pockels cell (model 350-50 KD*P; Conoptics, Danbury, CT, USA). Patch pipettes were pulled from borosilicate glass (Hilgenberg) with a PP-830 puller (Narishige) to resistances of 4-6 MW. To allow rapid loading of the cells, the series resistance was kept below 25 MW for at least 15 min after breaking into the cell.
FRAP recordings and data analysis As described in detail previously (Schmidt et al. 2003a) , two-photon FRAP experiments were performed between 30 and 120 min after the whole-cell configuration had been established using a custommodified Fluoview 300 laser-scanning microscope (Olympus, Hamburg, Germany) equipped with a mode-locked Ti : sapphire laser (Tsunami; Spectra Physics, Darmstadt, Germany) set to a centre wavelength of 765 nm. The laser intensity was modulated with a Pockels cell and focused on to the specimen by a 60 ·/0.9 NA water immersion objective (Olympus). The fluorescence was detected (photomultiplier tube) and sampled with the Fluoview system in the point mode (sampling frequency 250 kHz, 2 or 0.1-0.2 ms binning for cellular or aqueous FRAP recordings respectively). The laser intensity was set to a monitoring value of 4-10 mW (measured at the exit of the objective). After a 0.3-s baseline recording, a bleach pulse (1-6 ms, 35-65 mW) was applied and the recovery of the fluorescence monitored for 1.5 s. After recording the fluorescence signal, the specimen background, laser intensity and system background were recorded by defocusing, by deflecting scattered laser light towards the photomultiplier tube, and by completely blocking the laser beam, respectively, using the same intensity protocol.
Data analysis was performed with custom written routines in Igor Pro 5.02 (Wavemetrics, Lake Oswego, OR, USA). The fluorescence data were corrected for the specimen background, and the laser intensity data for the system background. The fluorescence was subsequently divided by the square of the laser intensity (Brown et al. 1999) , and normalized to the baseline fluorescence. Data were only accepted for analysis if the initial bleaching during the baseline period was less than 15%. The first second of the recovery of the axonal fluorescence (F) was fitted with a onedimensional diffusion equation of the form
where D is the diffusion coefficient, F ¥ is the postbleach fluorescence after recovery, F i is an offset from the prebleach amplitude (F 0 ¼ 1) which would indicate immobilization of PV*, b is the bleach depth parameter (Brown et al. 1999 ) and x r is the radial e )2 radius of the two-photon excitation volume.
Equation 1 was derived by first determining the time evolution of the concentration distribution in one dimension, which itself can be derived from the full three-dimensional (3D) case [equation V in Brown et al. (1999) ] by taking the limit as x r goes to infinity. The fluorescence signal is then determined by convolving this concentration distribution with a Gaussian beam profile. x r was determined from the lateral Gaussian profile of the point spread function (PSF) of our system, measured with 100-nm fluorescent microspheres (Molecular Probes) in water and injected into a cerebellar slice. Mean ± SD x r in water was 0.57 ± 0.05 lm and that in the tissue was 0.53 ± 0.01 lm (n ¼ 10). The percentage of total immobilized PV* (immobile fraction, IF) is 100 · F i /bleach depth. The bleach depth is the amplitude -measured from F 0 -of the signal immediately after the bleach pulse and related but not identical to b (Brown et al. 1999) . The first second of the somatic and nuclear recovery were described with the 3D diffusion equation given in Brown et al. (1999) , with an added offset to explore possible binding of PV* in these compartments: radius of the two-photon excitation volume (mean ± SD x z was 1.8 ± 0.1 lm in water and 1.95 ± 0.12 lm in slices). The parameters m and b represent the number of photons absorbed per molecule in a fluorescence and bleaching event respectively. Ignoring possible higher-order processes, we used m ¼ b ¼ 2, i.e. two-photon events. During fitting, the series were truncated after the sixth partial sum. The reliability of all fits was judged by inspection of the residuals (i.e. data -fit).
Results
FRAP principles and axonal mobility of PV* We used two-photon FRAP to analyse the mobility of Alexa-488-labelled parvalbumin (PV*) in PNs and to search for indications of PV binding partners. PNs were loaded with PV* via a somatic whole-cell patch pipette for at least 30 min before making FRAP recordings. The pipette contained 100 lM PV*, a concentration similar to or smaller than the assumed somatic or axonal concentration of native PV respectively (Kosaka et al. 1993) . After the 30-min equilibration time, the morphology of the cells (spines, dendrites, soma, nucleus, axon) could be clearly resolved under two-photon excitation, indicating that PV* had free access to all cellular compartments. For FRAP experiments the laser beam was directed to a single point of interest and a brief high-intensity laser pulse was applied to irreversibly bleach the fluorophores within the focal volume (FV). Subsequently, the recovery of the fluorescence, which reflects diffusion of unbleached PV* molecules from neighbouring regions into the FV, was monitored at low laser intensity (Fig. 1) .
The size of the FV was determined from the PSF of the microscope, measured with fluorescent microspheres with diameters (100 nm) well below the optical resolution. From the Gaussian profiles of the microsphere signal the radial (x r ) and axial (x z ) radii of the two-photon spot at the e )2 fluorescence intensity were determined to be 0.53 and 1.95 lm respectively. Thus, the axonal radius ($ 0.5 lm; Fig. 1 ) is smaller than x z and x r , and FRAP in the axon can be regarded as 1D diffusion in a pipe. In analogy to the 3D diffusion equation in Brown et al. (1999) , we derived a 1D diffusion equation for the axon (equation 1 in Experimental Procedures) that quantifies diffusional mobility in terms of the apparent diffusion coefficient (D). This equation well described individual as well as averaged recordings (Figs 1b and c respectively).
In FRAP experiments, binding of PV* to a large or immobile target would result in a steady-state offset from the prebleach level (Luby-Phelps et al. 1995; Star et al. 2002; Schmidt et al. 2005 ; for a detailed discussion of FRAP time courses see Reits and Neefjes 2001; Sprague et al. 2004) . In order to reveal such targets, our diffusion equation included an offset as an additional variable. Normalizing this offset to the maximum decrease in the fluorescence induced during bleaching (bleach depth) quantifies the immobile fraction (IF) of PV* (Luby-Phelps et al. 1995; Schmidt et al. 2003a Schmidt et al. , 2005 . In the example illustrated in Fig. 1(b) , the fluorescence fully returned to the prebleaching level (deviation < 1%), indicating that no IF of PV* was present in the axon. Averaging FRAP recordings obtained at different axonal sites significantly increased the signal-to-noise ratio (Fig. 1c) but yielded indistinguishable offsets. On average (54 FRAP recordings, five cells, three mice), the mean ± SEM IF was 1.7 ± 1.2%. This value was not significantly different from zero (t-test against a hypothetical distribution around zero that had a width and sample size identical to the distribution of the measured IFs). Thus, no significant binding of PV* to a large or immobile partner occurred in the axon.
The presence of small or rapid-kinetic binding partners would be characterized by a reduced diffusional mobility with a smaller D value but a full recovery of the fluorescence after bleaching ('retarded' or 'effective diffusion'; Crank 1995; Sprague et al. 2004) . Such interactions are not readily identified in FRAP recordings but require measurements in different cellular compartments as well as with substances that certainly lack cellular binding partners. Thus, we quantified D in the individual axonal recordings and derived a median value of 12 (IQR 6-20) lm 2 /s. By averaging recordings from the same axon, performed with identical protocols and showing similar bleach depths (Fig. 1c) , we could narrow the error range to a mean ± SEM of 12 ± 2 lm 2 /s. In spiny dendrites of PNs, the D of PV* has been reported to be 43 lm 2 /s (Schmidt et al. 2003a) , i.e. a value three to four times larger than the axonal D found here. In view of this discrepancy, we controlled the purity and quality of PV* by sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis (Fig. 2a) . A single protein band with an apparent molecular weight (M r ) slightly less than 15 kDa (expected M r $ 12 kDa) was seen in samples with the unlabelled PV and with PV*. As expected the band in the PV* sample migrated slightly more slowly than PV, in line with the small increase in M r due to the Alexa label. Thus, the reduced axonal mobility of PV does not result from an improper protein. We further tested whether our experimental approach and the original 3D equation (Brown et al. 1999 ; equation 2 in Experimental Procedures), from which our 1D equation was derived, yields results consistent with published D values. To this end, FRAP measurements were performed in an aqueous solution of 40-kDa FD (Fig. 2b) . Four independent samples of 50 averaged recordings each were fitted to equation 2, yielding a mean ± SEM D of 43 ± 5 lm 2 /s at 22°C. This estimate is almost identical to the value of 44 ± 5 lm 2 /s reported by Arrio-Dupont et al. (1996) .
Taken together, no technical aspects appeared to account for the observed difference between the axonal and dendritic PV* mobility. Thus, the discrepancy could be indicative of retarded diffusion owing to binding of PV* to a mobile axonal target. On the other hand, differences in cytoplasmic properties (i.e. viscosity and tortuosity) of dendrites and axons could also account for the discrepancy (Crank 1995; Sprague et al. 2004) . In order to distinguish between these two possibilities we performed axonal FRAP experiments with 10-kDa and 40-kDa FD, for which no cellular interaction partner would be expected. As for PV*, individual and averaged recovery curves were well described by our 1D diffusion equation for both dextrans (Fig. 3) . For 10-kDa FD, fluorescence recovery occurred with a median D of 10 (IQR 6-15) lm 2 /s (n ¼ 20, four cells, three mice), a value not statistically different from D PV *. The 40-kDa FD, however, recovered significantly more slowly from bleaching than PV* (p < 0.001; Mann-Whitney rank sum test). The median D was 5.5 (IQR 3-10) lm 2 /s (n ¼ 17, four cells, three mice). In spiny dendrites D values of 32 and 20 lm 2 /s have been reported for 10-kDa and 40-kDa FD respectively (Schmidt et al. 2003a) . These values are again three-to four-fold larger than the present axonal values. This indicates that the reduced axonal mobility of PV* was not due to a specific PV interaction, but instead more likely the result of differences in the cytoplasmic properties of dendrites and axons.
During the experiments, we distinguished between the axon initial segment ($ 20 lm from the soma; Clark et al. 2005) and the remainder of the axon. However, no differences were observed in D and IF values between these two axonal segments. Consequently, the data were pooled to represent the axonal mobility. Taken together, the data presented show that no large or immobile PV* binding ligand is present in the axon of PNs and further argue against any specific axonal PV* interactions with small and/or rapidkinetic partners.
Somatic and nuclear mobility of PV* We observed that PV* not only labelled the somata of PNs but also reached the nuclei, indicating that PV can readily pass the pores of the nuclear envelope. Because this property is a prerequisite for a transcription factor, such as the recently identified EF-hand CaBP downstream regulatory element antagonist modulator (DREAM) (Carrion et al. 1999) , in the next set of experiments we analysed FRAP of PV* in the soma and nucleus (Fig. 4) . FRAP in these two compartments is governed by 3D diffusion into the FV. Consequently, we used the previously published 3D diffusion equation (Brown et al. 1999) to quantify the somatic and nuclear PV* mobility.
We started by exploring possible immobilization of PV* in the soma or nucleus in terms of the IF that was introduced into the fitting function (see equation 2). The mean ± SEM IF in the soma was found to be )1 ± 1% and that in the nucleus was )1.1 ± 3% (Fig. 5a) . Thus, within the scatter range, the fluorescence completely recovered to the prebleaching level in both compartments, indicating that there was no significant interaction of PV with a large or immobile partner in either the soma or nucleus.
As in the axon, we next quantified the somatic and nuclear mobility of PV* in terms of the median D. In both compartments, it was found to be 11 lm 2 /s [somatic IQR 7-16 lm 2 /s (n ¼ 28); nuclear IQR 4-16 lm 2 /s (n ¼ 33); five cells each] (Fig. 5b) . This value is similar to D in the axon but smaller than that in spiny dendrites (Schmidt et al. 2003a) . Therefore, we again explored the possibility of retarded diffusion (see above) by performing FRAP experiments with 10-and 40-kDa FD in the soma and the nucleus. Fitting these data with the 3D diffusion equation yielded median D values of 9 (IQR 8-12) and 8 (IQR 7-10) lm 2 /s (n ¼ 10, three cells) for somatic and nuclear diffusion of 10-kDa FD respectively (Fig. 5b) . For 40-kDa FD, a signifi- /s (n ¼ 15); three cells each; p £ 0.001, MannWhitney rank sum test). Thus diffusion was three-to fourfold slower than that in dendrites (see above), providing evidence against specific PV* interactions in the soma and nucleus of PNs.
Relationship between diffusional mobility and molecular weight The Stokes-Einstein relationship predicts that in aqueous environments the D value of molecules much larger than water molecules is proportional to their hydrodynamic radius. Thus, for relatively large molecules, such as dextrans, D should be approximately proportional to the inverse cubic root of the M r (Pusch and Neher 1988; Koch 1999) . We previously found that this relationship holds for dextrans in dendrites, but is much steeper for CaBPs (Schmidt et al. 2003a (Schmidt et al. , 2005 .
We tested for the Stokes-Einstein relationship in axons, somata and nuclei by plotting the logarithms of the obtained (Fig. 5c ). For this analysis, the data of the three compartments were pooled. We found a good overlap for the dextran values, with a regression line with the slope set to ) 1/3. Similar to the situation in dendrites, a clear (but here non-significant) deviation of PV* from this line was observed. Thus, as in dendrites, the Stokes-Einstein relationships appear to hold approximately when comparing FDs of different M r in axons, somata and nuclei but presumably not in comparing FDs and proteins. This discrepancy is most likely explained by the tertiary structure of FDs and proteins (Kretsinger and Nockolds 1973; ArrioDupont et al. 1996) .
Given that the Stokes-Einstein relationship holds for FDs and an even steeper dependency might be expected for CaBPs (Schmidt et al. 2005) , we tried to estimate the smallest size of a PV binding ligand that would be revealed in our FRAP experiments with statistical confidence. To this end, we systematically varied the D values obtained for 10-kDa FD until we derived a D that was significantly smaller than D PV *. This 'statistically distinct D' takes into account the scatter of the data and the sample size. Based on the Stokes-Einstein relationship it was converted to a 'statistically distinct M r ' for a PV binding partner. This conversion yielded an upper limit for an undetected ligand of 9 kDa.
Discussion
Using two-photon FRAP experiments, we quantified diffusion of the endogenous CaBP PV in the axon, soma and nucleus of cerebellar PNs and found no indications for a PV binding ligand in these compartments. Because there was also no evidence in spiny dendrites for binding of PV to intracellular targets (Schmidt et al. 2003a ) our data substantiate the notion that, at least in PNs, PV functions as a Ca 2+ buffer and lacks a Ca 2+ sensor function. Diffusional exchange between neuronal dendrites and spines is often quantified by exponential fitting of FRAP time courses (Svoboda et al. 1996; Majewska et al. 2000; Star et al. 2002; Schmidt et al. 2003a Schmidt et al. , 2005 . In order to provide comparability between different cellular compartments, this approach requires conversion of the time constants (s) into D values. Because s is related to D by the morphology of the structure under investigation, this presupposes a detailed anatomical knowledge. For example, the spino-dendritic s reflects diffusion through a pipe (the spine neck), whereas the axonal s results from diffusion within a pipe. Obviously, s values cannot be compared directly. Our equation for 1D diffusion offers the advantage that a detailed knowledge of the morphology under investigation is not required, as long as the diameter of the cellular structure is well below the axial and radial extension of the FV. Thus, the present approach can be applied to thin cylindrical structures such as axons and distal dendrites.
The possibility of PV binding to target molecules was explored in two ways: in terms of the IF, which is revealed by an incomplete recovery of fluorescence after bleaching, and by comparing the diffusional mobility of PV* with that of 10-and 40-kDa FD. It has been shown previously that the IF is a convenient measure to identify intracellular targets of dye-labelled proteins if the following criteria are met. First, the target molecule has to be immobile or at least of considerable size and, second, the off rate of the interaction has to be small compared with the diffusional mobility (Luby-Phelps et al. 1995; Reits and Neefjes 2001; Star et al. 2002; Sprague et al. 2004; Schmidt et al. 2005) . Thus, the observed absence of an IF in all three compartments argues against the presence of a large or immobile PV ligand.
In the axon, the absence of an IF came to some extent as a surprise. Based on quantitative immunogold staining, the PV concentration in axons of rat PNs has been estimated to be $ 1 mM and $ 100 lM in somata and dendrites (Kosaka et al. 1993) , suggesting partial immobilization of PV in the axon as a possible adsorption mechanism. How can we reconcile this discrepancy with our FRAP data? First, it could be that PV is incorporated into a stable protein complex, such that our dye-labelled PV could not replace the native PV. However, given that our experiments were performed between 30 and 120 min in the whole-cell configuration, this would require complex stabilities of several hours, which we consider unlikely. Second, in several cases it was observed that CaBP antibody recognition depends on the Ca 2+ -binding status of the protein (Winsky and Kuznicki 1996; Zimmermann and Schwaller 2002; B. Schwaller and P. Racay, unpublished data) . Thus, differences in the metal-binding status of PV in different compartments might yield 'apparent' concentration differences. Finally, the previously reported densities of immunogold particles in axons and somata or dendrites varied by a factor of only 2.5 (Kosaka et al. 1993) . The subsequent concentration estimate was based on an in vitro standard curve that showed a strong non-linearity above PV concentrations of $ 100 lM, rendering the concentration estimates between 100 lM and 2 mM rather error prone. Taken together, there is no obvious cause for the discrepancy between the immunohistochemical data and our FRAP data. This topic requires further investigation.
FRAP in the presence of small or rapid-kinetic binding partners is characterized by retarded diffusion with a smaller D value but a full fluorescence recovery after bleaching ('effective diffusion'; Crank 1995; Sprague et al. 2004) . We found that D PV * values in axons, somata and nuclei were three times smaller than those in spiny dendrites of rodent PNs (Schmidt et al. 2003a ) and in frog myoplasm (Maughan and Godt 1999) . This raised the possibility of 'retarded diffusion' of PV* owing to the existence of a small, nondendritic binding partner. Based on experiments performed with FDs, however, we exclude the existence of PV* interaction sites with M r ‡ 9 kDa. Thus, the reduced mobility may be explained either by systematic errors in our experimental approach or by differences in cytoplasmic properties between dendrites and axons; it is unlikely to reflect specific interactions.
The experimental and theoretical approach taken here has previously been shown to yield D values for green fluorescent protein diffusion consistent with the literature (Swaminathan et al. 1997; Brown et al. 1999) . Furthermore, in the present study we demonstrated that the aqueous mobility of 40-kDa FD is also consistent with published values (Arrio-Dupont et al. 1996) , making it unlikely that our experimental design or mathematical formulae led to systematically reduced D values. Thus, we consider differences in the cytoplasmic properties as a more likely cause. These may include the viscosity, tortuosity, and the density of fibres or organelles in the respective cytosolic compartments. For example, microtubules in axons are usually more closely spaced than those in dendrites. Furthermore, although characteristic somatic organelles such as the Golgi apparatus or rough endoplasmic reticulum extend into proximal dendritic structures, they diminish at more distal sites (Fiala and Harris 2005) . In the nucleus a high concentration of chromatin (Lafarga et al. 1991) could contribute to the reduced mobility of PV*.
To conclude, we have presented evidence that PV lacks specific intracellular targets in cerebellar PNs and so probably functions as a pure Ca 2+ buffer in these cells. The obtained D values provide a foundation for realistic simulations of neuronal Ca 2+ signalling in the presence of PV.
